Viewing Study NCT04989218


Ignite Creation Date: 2025-12-25 @ 4:43 AM
Ignite Modification Date: 2025-12-26 @ 3:44 AM
Study NCT ID: NCT04989218
Status: TERMINATED
Last Update Posted: 2024-11-05
First Post: 2021-07-09
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
Sponsor: University of Alabama at Birmingham
Organization: